Drreddys Laboratories reported $28.74B in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Aurora Cannabis Inc ACB:CN -52930000 16.56M
Bayer BAYN:GR 7.14B 2.32B
Canopy Growth Corp WEED:CN C$ -1392000 157.85M
Catalent CTLT:US $ 423M 18M
Cipla CIPLA:IN 33.51B 2.37B
Corcept Therapeutics CORT:US $ 102.07M 9.63M
Endo International Ordinary Shares ENDP:US $ 472.5M 94.46M
GlaxoSmithKline GSK:LN 4.79B 1.34B
Hikma Pharmaceutical HIK:LN 623M 62M
Horizon Pharma HZNP:US $ 646.2M 23.99M
JAZZ PHA JAZZ:US $ 808.67M 110.23M
Lannett LCI:US $ 3.08M 2.63M
Lonza Group LONN:SW 1.2B 129M
Novartis NOVN:VX 9.34B 277M
Pacira Pharmaceuticals PCRX:US $ 118.78M 3.13M
Phibro Animal Health PAHC:US $ 71.63M 0.95M
Prestige Brands PBH:US $ 160.12M 11.26M
Richter Gedeon RICHT:HB 110.04B 14.05B
Sun Pharmaceuticals SUNP:IN IR 78615.6M 9544.3M
Supernus Pharmaceuticals SUPN:US $ 149.59M 15.02M
Teva Pharmaceutical TEVA:IT 1.83B 26M